Innovative management of Anterior Cutaneous Nerve Entrapment Syndrome (ACNES): A meta-analysis and introduction of a new robotic approach with patient-based algorithm.

Am J SurgJul 1, 2026 (epub)
Clinical ResearchGeneral Surgery

Carlos Balthazar da Silveira, Snigdha Gulati, Robert Easter et al.

✦ AI-curated · Sources linked

In 30 seconds

This meta-analysis evaluated treatments for Anterior Cutaneous Nerve Entrapment Syndrome (ACNES), analyzing both non-operative and surgical outcomes. The study found a non-operative success rate of 35% and a surgical success rate of 94.45%, with a recurrence rate of 34.6% after surgery. A standardized management algorithm and nomenclature were proposed.

Key findings

  • Non-operative success rate for ACNES was 35%.
  • Surgical success rate reached 94.45%.
  • Recurrence rate after the first surgery was 34.6%.
  • Significant heterogeneity in definitions of neurectomies was observed.

Why it matters

Understanding the varying success rates of treatments for ACNES is crucial for clinicians to make informed decisions. The high recurrence rate after surgery highlights the need for individualized patient management based on symptom severity and expectations.

Source

Published in Am J Surg. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in General Surgery

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.